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ABSTRACT: Sex hormones may exert neuroprotective effects in
various models of brain lesions. Male and female Long–Evans
rats were subjected to intracerebroventricular injections of 2µg
192 IgG-saporin or vehicle. Starting 2 days before surgery, half
the male rats were treated with estradiol for 7 days. Three
weeks after surgery, they were sacriﬁced for histochemical
staining of acetylcholinesterase (AChE) and densitometric eval-
uations. The lesion induced a substantial to dramatic decrease
of the AChE-positive ﬁber density in the cingulate, somatosen-
sory, piriform, retrosplenial and perirhinal cortices, and in the
hippocampus. Weak effects were found in the striatum. There
was no signiﬁcant decrease in the dorsal thalamus. Sex had no
signiﬁcant effect on AChE-positive staining in any brain area.
In males, estradiol treatment did not alter the effects of 192
IgG-saporin. These results show that sex or estradiol treatment
in male rats does not interfere with the immunotoxic effects of
intracerebroventricular injections of 192 IgG-saporin on cholin-
ergic projections from the basal forebrain. © 2002 Elsevier
Science Inc. All rights reserved.
KEY WORDS: 192 IgG-saporin, AChE, Basal forebrain, Sex,
Immunotoxin, Rat, Estrogen.
INTRODUCTION
Until recently, the functions of the cholinergic neurons in the basal
forebrain have been investigated using various lesion techniques
[4,5,37]. With 192 IgG-saporin, a monoclonal antibody (192 IgG)
raised against the low affinity nerve growth factor receptor (p75NGF
receptor) coupled to the ribosome-inactivating toxin saporin (from
Saponaria officinalis), it became possible to damage cholinergic
neurons in the basal forebrain more selectively [38]. This immuno-
toxin can be injected into the ventricular system (i.c.v.), choliner-
gic nuclei (nucleus basalis magnocellularis, medial septum, diag-
onal band of Broca) or cholinergic target fields [17,23,27]. Such
injections induce a more or less extensive cholinergic denervation
of the hippocampus, the cortex, or of both, for instance in case of
i.c.v. injections [23,26,36].
In a recent article in which 192 IgG-saporin was injected into
the nucleus basalis magnocellularis, McGaughy and Sarter [25]
mentioned that the basal forebrain cholinergic neurons of female
rats might be more sensitive to 192 IgG-saporin than those of male
rats [24]. In our laboratory, male and female Long–Evans rats have
been subjected to virtually identical lesions (2µg 192 IgG-saporin
into the lateral ventricles), but the greatest cholinergic damage and
cognitive impairments were found in males (unpublished data vs.
Lehmann et al. [23]).
Beyond the apparent discrepancy, such observations might
indicate that the status of sex hormones in the experimental
subjects might interfere with the efficiency of the immunotoxin.
The role of hormones (e.g., estrogen or progesterone) in neu-
roprotection has been reviewed in many articles (for recent re-
views: [2,7,8,15,30,32,40]) including those focused on aging (e.g.,
[9,11,12,31]) and special attention was paid to the cholinergic
basal forebrain system (e.g., [1,10,22]). Most of the literature in
that research field provide evidence for protective effects of estro-
gen after ischemia, axotomy or exposure to some neurotoxins [7].
However, it is not clear whether estrogen may exert its protec-
tive effects for all types of insults. For instance, Hörtnagl et al. [18]
reported that female rats on proestrus exhibited increased sensi-
tivity to the neurotoxic action of AF64A injected intracerebroven-
tricularly, and Aggarwal and Gibbs [1] recently demonstrated that
male and female rats showed comparable damage after injection
of ibotenic acid into the nucleus basalis magnocellularis or after
transection of the fimbria–fornix pathways.
Additionally, it is noticeable from the literature that, among
various mechanisms thought to be involved in the neuroprotec-
tion induced by estrogen treatment, evidence supports the role
of estrogen as a modulator of neuronal growth factor systems
[3,13,19,33]. Interestingly, the p75NGF receptor was shown to
be colocalized with the estrogen receptor in cholinergic neurons
of the basal forebrain [33,34]. Moreover, estrogen replacement
resulted in significant decrease of p75NGF mRNA and protein,
attenuated the loss of p75NGF immunoreactivity following transec-
tion of the fimbria–fornix [13,14], and decreased the expression of
neurotrophins [19] in basal forebrain cholinergic nuclei. As 192
IgG-saporin exerts its effects through the p75NGF receptor, it might
be hypothesized that the hormonal status of rats may interact with
the efficiency of the immunotoxin.
In the present experiment, we report on the effects of i.c.v. in-
jections of 192 IgG-saporin on acetylcholinesterase (AChE) histo-
chemistry in male and female rats, and in male rats treated with
β-estradiol-3-benzoate for 2 days before and 5 days after surgery.
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MATERIALS AND METHODS
Subjects and Design
All procedures involving animals and their care were conducted
in conformity with the institutional guidelines that are in compli-
ance with national (council directive #87848, October 19, 1987,
Ministère de l’Agriculture et de la Foreˆt, Service Vétérinaire de la
Santé et de la Protection Animales; permission # 6212 to J.-C.C.
and 6714-bis to H.J.; O.L., F.B. and R.G. under the former’s re-
sponsibility) and international (NIH publication, No. 86-23, revised
1985) laws and policies.
Our study used 20 male and 12 female Long–Evans rats (R.
Janvier, France) aged about 90 days at the time of surgery (males:
321 ± 2.9 g; females: 201 ± 5.1 g). Two days before surgery,
eight male rats were treated with subcutaneous (s.c.) injections of
β-estradiol-3-benzoate (groups ML+E, n = 4 and MS+E, n = 4)
whilst all other rats received injections of the vehicle (peanut oil).
During surgery, all rats from the group ML + E, six other male
rats (ML) and six female rats (FL) received bilateral infusions of
192 IgG-saporin. The other rats were Sham-operated (FS, n = 6;
MS, n = 5). All rats were housed in transparent Makrolon cages
(42 cm× 26 cm× 15 cm) under a 12:12 h dark–light cycle (lights
on at 0700 h), with ad lib. access to food and water throughout the
experiment. The colony and testing rooms were under controlled
temperature (21◦C).
Surgeries and Estradiol Treatment
All surgical procedures were conducted under aseptic con-
ditions. A mixture of ketamine (6.75 mg/kg, i.p.) and xylazine
(0.85 mg/kg, i.p.) was used for anaesthesia. Injections of 192
IgG-saporin (ATS, San Diego, USA; 1µg/µl per lateral ventricle,
concentration 1µg/µl of PBS) or PBS into the lateral ventricles
were performed stereotaxically through a 2-µl Hamilton syringe at
the following coordinates (in mm): A −0.8 (from Bregma), L ±1.4
(from the midline), V −4.3 (from Bregma) for males, and A −0.8
(from Bregma), L ±1.3 (from the midline), V −4.1 (from Bregma)
FIG. 1. Different areas in which the density of the AChE-positive reaction products were measured. All
counts were taken bilaterally. Abbreviations: cc: cingulate cortex, dg: dentate gyrus, ds: dorsal striatum,
dt: dorsal thalamus, h: hippocampus CA1, pc: piriform cortex, pr: perirhinal cortex, rc: retrosplenial
cortex, sc: somatosensory cortex, vs: ventral striatum.
for females, with the incisor bar set at the interaural line [28].
After each injection, the needle was left in situ for 9 min before
being slowly retracted. In all Sham-operated rats of both sexes, a
volume of 1µl of PBS was injected into each lateral ventricle.
In rats, from groups MS+E and ML+E, the estradiol treatment
(β-estradiol-3-benzoate, 20µg/ml kg in peanut oil injected (s.c.);
Sigma, St. Louis, USA) was started 2 days before surgery and
continued over 7 consecutive days. The rats from the other groups
were injected daily with 1 ml/kg of peanut oil (s.c.) over the same
period of time.
Histochemical Verifications
After 21 days, all rats were sacrificed for histochemical verifi-
cations.
The rats were injected with an overdose of pentobarbital
(100 mg/kg, i.p.; Sanofi, France) and transcardially perfused with
60 ml of saline followed by 60 ml of 0.1 M phosphate-buffered
paraformaldehyde (4◦C, pH 8). After extraction and post-fixation
for about 4 h, the brains were placed in a cryoprotective solu-
tion (0.1 M phosphate-buffered 20% sucrose solution) for about
36 h before being frozen and stored at −80◦C. Using a cryostat
(−23◦C), the brains were cut into 30-µm thick coronal sections
which were collected on gelatine-coated slides. The sections were
dried at room temperature for at least 36 h and stained for AChE
according to a method similar to that described by Koelle [20].
Ethopropazine (0.3 mM; Sigma, St. Louis, USA) was used to
block non-specific cholinesterases and acetylthiocholine iodide
(4 mM; Sigma, St. Louis, USA) was used as the substrate.
Evaluation of AChE-Density
The quantification of AChE-positive reaction products was as-
sessed by an adaptation of a method described by Turchi and Sarter
[35]. The various locations in which the measurements were made
are shown in Fig. 1. Briefly, an AChE staining index was ob-
tained by measuring the exposure time (in seconds) indicated by
a Vanox Olympus Microscope (model AHBT) when the apparatus
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FIG. 2. Examples of AChE-density in the frontal cortex and the striatum (A–C), the hippocampus and the dorsal thalamus
(D–F) in Sham-operated male rats (A, D), in male rats given 192 IgG-saporin (B, E) and in female rats given 192 IgG-saporin
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was switched into the photograph mode (ISO 100, reciprocity: 0,
exposure adjustment: 1, magnification: 10 × 5) and the objective
was focused on different areas of each section (see Fig. 1). A total
of 22 measures for each hemisphere were taken from four sections
of each brain. Four measures were taken at 1.00 mm anterior and
1.40 mm posterior to Bregma (cingulate, somatosensory, piriform
cortices and striatum), and seven measures were taken at 3.60 and
4.52 mm posterior to Bregma (retrosplenial, somatosensory, piri-
form and perirhinal cortices, hippocampal CA1, dentate gyrus and
dorsal thalamus). A minimal and constant exposure time of 1.12 s
was found in regions where there were no AChE-positive reac-
tion products at all (i.e., in a totally denervated cortical region in
rats given 192 IgG-saporin). This 1.12-s value was considered a
“background” (section without AChE-positive staining, gelatine,
slide and cover-glass) and subtracted from all measures before
analysis. All measurements were made by the same experimenter
who was unaware of the sex, the surgical or the pharmacological
treatment of the rats.
Statistical Analysis
The AChE-positive fiber density from the left and right hemi-
spheres of each measurement area were first averaged. These aver-
age values were then analyzed by analyses of variance (ANOVA),
followed where appropriate, by 2 × 2 comparisons based on the
Newman–Keuls multiple range test [39]. A first analysis was made
according to a 2 (Male, Female)× 2 (Sham, Lesion) design in or-
der to assess the effects of the sex and the lesion (male rats given
estradiol were not considered). A second analysis was made ac-
cording to a 2 (Sham, Lesion)× 2 (Oil, Estradiol) design on all
male rats in order to assess the effects of the lesion and of estra-
diol. One ML rat died from an anesthetic shock and another one
was subjected to euthanasia a few days prior to the scheduled sac-
rifice date because of respiratory disease. The results from these
rats were not considered for statistical analysis.
RESULTS
Overall, the i.c.v. injections of the toxin induced a profound
depletion of AChE-positive reaction products in almost all cortical
areas, as well as over the entire hippocampus (Cornu Ammonis+
dentate gyrus). These observations, illustrated in Figs. 2A–F, were
confirmed by the measurements shown in Tables 1 and 2.
The first analysis was performed on the rats not treated with
estradiol, that is MS, ML, FS and FL rats. It showed a significant
overall Lesion effect at all four levels from Bregma [F(1, 14) =
6.95 at least and 128.26 at most, 0.05 > p > 0.001] and in all
cortical and hippocampal regions assessed. This effect was due to
a 50% decrease at least of the AChE-positivity in all lesioned rats
as compared to their Sham-operated counterparts. In the dorsal
thalamus, there was no significant overall Lesion effect, whether
at −3.6 or −4.5 mm from Bregma (see Table 1). In the striatum,
the effects were not very consistent and, when significant, they
were much less pronounced than in the other brain regions. In
the dorsal striatum, there was a significant effect of the lesion at
+1.0 mm from Bregma. In the ventral striatum, the Lesion effect
was significant at both anteriority levels [F(1, 14) = 6.56, at least,
p < 0.05]. Whatever level or brain region was considered, we
could not find any statistical evidence for a significant overall effect
of Sex, nor a significant effect of the Lesion× Sex interaction.
The analysis of the data from all male rats, that is rats from
MS + E, MS, ML + E and ML groups, showed a significant Le-
sion effect at all four anteroposterior levels [F(1, 14) = 6.57 at
least and 172.37 at most, 0.05 > p > 0.001] and in all cortical
and hippocampal regions assessed. This effect was due to a de-
crease of the AChE-positivity in all lesioned rats as compared to
their Sham-operated counterparts (−50% at least). In the dorsal
thalamus, there was no significant Lesion effect, whether at −3.6
or −4.5 mm from Bregma (see Table 2). In the striatum, the effects
were not as consistent and, when significant, they were much less
pronounced than in the other brain regions. In the dorsal striatum,
there was no significant effect of the lesion at both anteriority lev-
els. In the ventral striatum, the Lesion effect was significant at both
anteriority levels [F(1, 14) = 6.56, at least, p < 0.05]. Whatever
anteroposterior level or brain region was considered, we could not
find any statistical evidence for a significant overall effect of Estro-
gen treatment, nor for a significant effect of the Lesion×Estrogen
interaction.
DISCUSSION
The present results show that bilateral i.c.v. injections of 192
IgG-saporin induced a consistent and significant decrease of the
AChE-positive fiber density in various cortical regions (cingulate,
somatosensory, piriform, retrosplenial and perirhinal), as well as
in the Cornu Ammonis and the dentate gyrus of the hippocampus.
Conversely, the immunotoxin produced much less pronounced
cholinergic damage in the striatum and no significant effect
in the dorsal thalamus. Otherwise, considering all measures of
AChE-positivity, there was no significant difference between male
and female rats, and estradiol treatment did not alter the effects of
192 IgG-saporin in male rats.
When injected into the cerebral ventricles, 192 IgG-saporin kills
cholinergic neurons of the basal forebrain and Purkinje cells of the
cerebellum. This latter cell type is not only cholinergic but it also
bears p75NGF receptors [41]. Damage to the cholinergic neurons
of the basal forebrain accounts for the extensive denervation of
different cortical regions and of the hippocampus. In the present
study, the cortical and hippocampal denervations produced by 192
IgG-saporin confirm previous results from the literature [41].
In adult rats, it is generally considered that cholinergic interneu-
rons of the striatum bear few p75NGF receptors (although present
at birth and re-expressed in adults after striatal lesions [6,21]) and,
therefore, should not be very sensitive to the immunotoxin. This
is also the case with the cholinergic innervation of other structures
such as the thalamus [41]. Although there was no significant ev-
idence for thalamic denervation in the present study, our data in-
dicate a reduction of AChE-positivity in the striatum. In a recent
article, Perry et al. [29] presented brain sections from rats given
intraseptal infusions of 192 IgG-saporin. On one of these sections,
the striatum was almost completely devoid of AChE-staining. In an
earlier report, Heckers et al. [16] also reported reduced choliner-
gic markers in the striatum after injections of 192 IgG-saporin into
the basal forebrain. Altogether, these data suggest that cholinergic
striatal interneurons may indeed be vulnerable to 192 IgG-saporin
injected into the basal forebrain or into the cerebral ventricles.
In 1999, McGaughy and Sarter [25] stated that cholinergic
neurons of the basal forebrain might be more sensitive to 192
IgG-saporin in female than in male rats. In our previous experi-
ments, rats had been subjected to virtually identical lesion tech-
niques (2µg 192 IgG-saporin into the lateral ventricles), and we
found cholinergic damage and cognitive impairments which were
larger in male than in female rats (unpublished data on males vs.
Lehmann et al. [23]). Beyond the possibility that these differences
could be due to a variable potency from one batch to another,
one cannot exclude a priori that the differential effects of 192
IgG-saporin might also be explained by a factor related to the sex
of rats (i.e., sex hormones). The effects of estrogen on neuropro-
tection have been widely studied and these effects were shown to
be mediated by the classical nuclear estrogen receptors, but also by
other membrane receptors, by the modulation of neurotransmitter
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receptor function or by its anti-oxidant effects [7]. The effects of
estrogen have also been attributed to interactions between neu-
rotrophin (e.g., p75NGF) and estrogen receptors [13,14,19]. Thus,
we expected that the cholinergic effect of the immunotoxin would
be different, i.e., be larger or smaller, depending on a differential
regulation of p75 receptors between male and female rats and/or
between males treated with estradiol and males not subjected to
this treatment. Our results showed that the male rats not treated
with estradiol and the female rats presented a comparable reduc-
tion of AChE-positive reaction products in the cortex and the hip-
pocampus. The results also showed that treatment with estradiol at
a daily dose of 20µg/ml kg during 7 days did not alter the effect
of the immunotoxin. It is, however, noteworthy that the effects of
estrogen on cholinergic neurons may depend upon the dose and the
duration of the treatment [10,12]. For instance, Gibbs [10] reported
that 25 or 100µg estradiol repeatedly administrated over 4 weeks
to ovariectomized rats resulted in a significant decrease of the num-
ber of p75NGF immunoreactive cells in the medial septum. Gibbs
[10] also found that such a decrease was not observed after a 1- or
2-week treatment period at the same doses, or after a longer treat-
ment period at lower doses. Thus, even though it remains possible
that the variability of batch potency may account for the different
effects of 192 IgG-saporin between males and females in previous
experiments, we cannot exclude that, in the present experiment,
the dose and the duration of estradiol treatment in male rats may
have been too short to alter the effects of 192 IgG-saporin. This
hypothesis needs to be tested in further experiments using i.c.v.
or intraparenchymal injections of various doses of the cholinergic
immunotoxin in combination with a control of the estrous cycle at
the time of injection.
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